NMAD: Lixte Biotechnology Holdings Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-31 | New 13G stake | Vanguard Capital Management | 5.02% | SEC |
Institutional ownership (Q2 2026)
18 institutions reported holding $14.28M of Lixte Biotechnology Holdings Inc on Form 13F (14 the quarter before). 9 opened a new position and 5 sold out. Shares held by institutions: +170%.
| Largest holders | Shares | Value |
|---|---|---|
| Legacy Wealth Managment, LLC/ID | 600,669 | $4.46M |
| VANGUARD CAPITAL MANAGEMENT LLC | 555,476 | $4.12M |
| SCOTIA CAPITAL INC. | 283,162 | $2.10M |
| GEODE CAPITAL MANAGEMENT, LLC | 143,036 | $1.06M |
| BlackRock, Inc. | 75,958 | $564K |
| STATE STREET CORP | 75,096 | $557K |
| VANGUARD FIDUCIARY TRUST CO | 67,280 | $499K |
| Federation des caisses Desjardins du Quebec | 38,130 | $283K |
| NORTHERN TRUST CORP | 27,655 | $205K |
| AXXCESS WEALTH MANAGEMENT, LLC | 13,771 | $102K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.